ArticleJournal of general internal medicine2018
Taking an Interdisciplinary Approach to Understanding and Improving Medication Adherence.
Article in Journal of general internal medicine, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06232603 (Assessing Medication Adherence in Patients With Chronic Recurrent Multifocal Osteomyelitis), which is not on this map. Cited by 6 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Assessing Medication Adherence in Patients With Chronic Recurrent Multifocal Osteomyelitis
Who cites it
6 citing papers in PubMed.
- Interdisciplinary Perspectives on Patient Adherence to Therapy: Findings from a Qualitative Study.Healthcare (Basel, Switzerland) · 2026Article
- Improving medication adherence in cardiovascular disease.The British journal of cardiology · 2026Article
- Developing and testing a web-based platform for antiretroviral therapy (ART) adherence support among adolescents and young adults (AYA) living with HIV.PEC innovation · 2024Article
- Adherence to Medications in Patients with Ischaemic Heart Disease in Oman.Sultan Qaboos University medical journal · 2024Article
- Navigating the Challenges: Predictors of Non-Adherence to Psychotropic Medications Among Patients with Severe Mental Illnesses in Ethiopia.Patient preference and adherence · 2023Article
- Real-world persistence with liraglutide 3.0 mg for weight management and the SaxendaCare® patient support program.Obesity science & practice · 2020Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.